TherapeuticsMD, Inc. — Director's Dealing 2012

Mar 2, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2012-02-29

Reporting Person: SEGAL NICHOLAS (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	245485	Direct
Common Stock	3549805	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-Qualified Stock Option	$0.1874	2020-05-01	Common Stock (92057)		Direct

Footnotes

F1: Mr. Segal owns 11.5812% of Fourth Generation Private Equity equal to 411,110 shares. Mr. Segal disclaims beneficial ownership to the remaining shares owned by Fourth Generation Private Equity.